Acute toxicity associated with the recreational use of the novel dissociative psychoactive substance methoxphenidine

Clinical Toxicology

Volumn 52, Issue 10, 2014, Pages 1288-1291

  Hofer, Katharina E ^a   Degrandi, Colette ^a   Müller, Daniel M ^b   Zürrer Härdi, Ursina ^c   Wahl, Schirin ^c   Rauber Lüthy, Christine ^a   Ceschi, Alessandro ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c TRIEMLI HOSPITAL   (Switzerland)

Author keywords

2 MeO diphenidine; Designer drug; Diarylethylamine; Drug of abuse; Ketamine; NMDA receptor; Phencyclidine; Psychedelic

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; CREATINE KINASE; CREATININE; DESIGNER DRUG; GAMMA GLUTAMYLTRANSFERASE; LORAZEPAM; METHOXPHENIDINE; PHENCYCLIDINE; PSYCHOTROPIC AGENT; RECREATIONAL DRUG; UNCLASSIFIED DRUG; 1-(1-(2-METHOXYPHENYL)-2-PHENYLETHYL)PIPERIDINE; BIOLOGICAL MARKER; PIPERIDINE DERIVATIVE; STREET DRUG;

ACUTE TOXICITY; ADULT; AGITATION; AMNESIA; ARTICLE; CASE REPORT; CONFUSION; DRUG IDENTIFICATION; DRUG USE; ECHOLALIA; GLASGOW COMA SCALE; HUMAN; HYPERTENSION; LIQUID CHROMATOGRAPHY; MALE; MASS FRAGMENTOGRAPHY; NYSTAGMUS; OPISTHOTONUS; OXYGEN SATURATION; PHYSICAL EXAMINATION; TACHYCARDIA; TANDEM MASS SPECTROMETRY; TEMPERATURE; TURBULENT FLOW; ADDICTION; BIOTRANSFORMATION; BLOOD; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CHEMICALLY INDUCED; COMPLICATION; DRUG EFFECTS; MIDDLE AGED; NERVOUS SYSTEM; NEUROTOXICITY SYNDROMES; PATHOPHYSIOLOGY; TREATMENT OUTCOME; URINE;

BIOLOGICAL MARKERS; BIOTRANSFORMATION; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CHROMATOGRAPHY, LIQUID; CONFUSION; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM; NEUROTOXICITY SYNDROMES; PIPERIDINES; PSYCHOTROPIC DRUGS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; TANDEM MASS SPECTROMETRY; TREATMENT OUTCOME;

EID: 84919954055     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2014.974264     Document Type: Article

References (15)

1. Morris H, Wallach J. From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Test Anal 2014; 6:614-632.
2. Gray NM, Cheng BK. EP patent 0346791, Preparation of " 1, 2-diarylethylamines for treatment of neurotoxic injury ". EU Patent No 0346791A1. 1989, assigned to G.D. Searle & Co.
3. http://www.bluelight.org/vb/threads/700834-The-Big-and-Dandy-Methoxphenidine-(MXP-2-MeO-Diphenidine)-Thread (Last accessed on August 18, 2014).
4. https://www.erowid.org/experiences/subs/exp-2MeODiphenidine. shtml (Last accessed on August 18, 2014).
5. Mueller DM, Duretz B, Espourteille FA, Rentsch KM. Development of a fully automated toxicological LC-MS(n) screening system in urine using online extraction with turbulent f ow chromatography. Anal Bioanaly Chem 2011;400:89-100.
6. http://www.eve-rave.ch/Forum/viewtopic.php?f = 106&t = 33408 (Last accessed on August 18, 2014).
7. Wood DM, Davies S, Puchnarewicz M, Johnston A, Dargan PI. Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. Eur J Clin Pharmacol 2012; 68:853-856.
8. Dillon P, Copeland J, Jansen K. Patterns of use and harms associated with non-medical ketamine use. Drug Alcohol Depend 2003; 69:23-28.
9. McCarron MM, Schulze BW, Thompson GA, Conder MC, Goetz WA. Acute phencyclidine intoxication: clinical patterns, complications, and treatment. Ann Emerg Med 1981; 10:290-297.
10. Fujimura H, Kawai K. Pharmacological studies on diphenylalkylam-ine derivatives. (I). Bull Inst Chem Res Kyoto University 1961; 39:67-77.
11. Baselt RC. Cocaine. In: Baselt RC, ed. Disposition of Toxic Drugs and Chemicals in Man. 9th ed. Chicago, IL: Year Book Medical Publishers; 2002:390-394.
12. Preston KL, Silverman K, Schuster CR, Cone EJ. Assessment of cocaine use with quantitative urinalysis and estimation of new uses. Addiction 1997; 92:717-727.
13. Morgan CJ, Muetzelfeldt L, Curran HV. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study. Addiction 2010; 105:121-133.
14. Yu WL, Cho CC, Lung PF, Hung EH, Hui JW, Chau HH, et al. Ketamine-related cholangiopathy: a retrospective study on clinical and imaging findings. Abdom Imaging 2014 Jun 17. [Epub ahead of print].
15. Wang C, Zheng D, Xu J, Lam W, Yew DT. Brain damages in ketamine addicts as revealed by magnetic resonance imaging. Front Neuroanat 2013; 7:23.